Email
Print
Non-Alcoholic Steatohepatitis Market - Forecast(2024 - 2030)
1. Non-Alcoholic Steatohepatitis Market - Overview
1.1 Definitions and Scope
2. Non-Alcoholic Steatohepatitis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Non-Alcoholic Steatohepatitis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Non-Alcoholic Steatohepatitis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Non-Alcoholic Steatohepatitis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Non-Alcoholic Steatohepatitis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Non-Alcoholic Steatohepatitis Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Non-Alcoholic Steatohepatitis Market - By Sale Channel (Market Size -$Million / $Billion)
1.1 Definitions and Scope
2. Non-Alcoholic Steatohepatitis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Non-Alcoholic Steatohepatitis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Non-Alcoholic Steatohepatitis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Non-Alcoholic Steatohepatitis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Non-Alcoholic Steatohepatitis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Non-Alcoholic Steatohepatitis Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Non-Alcoholic Steatohepatitis Market - By Sale Channel (Market Size -$Million / $Billion)
8.1 Hospital Pharmacy
8.2 Online Provider
8.3 Retail Pharmacy
9. Non-Alcoholic Steatohepatitis Market - By Drug Type (Market Size -$Million / $Billion)
9.1 Vitamin E Pioglitazone
9.2 Obeticholic Acid
9.3 Elafibranor
9.4 Selonsertib Cenicriviroc
10. Non-Alcoholic Steatohepatitis - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Non-Alcoholic Steatohepatitis- By Geography (Market Size -$Million / $Billion)
11.1 Non-Alcoholic Steatohepatitis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Non-Alcoholic Steatohepatitis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Non-Alcoholic Steatohepatitis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Non-Alcoholic Steatohepatitis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Non-Alcoholic Steatohepatitis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Non-Alcoholic Steatohepatitis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Non-Alcoholic Steatohepatitis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Non-Alcoholic Steatohepatitis Market - Key Company List by Country Premium
15. Non-Alcoholic Steatohepatitis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Allergan Plc
15.3 Cadila Healthcare Ltd
15.4 Conatus Pharmaceuticals, Inc
15.5 Galmed Pharmaceutical Ltd
15.6 Gemphire Therapeutic Inc
15.7 Genfit Sa
15.8 Gilead Sciences, Inc
15.9 Intercept Pharmaceuticals, Inc
15.10 Novartis International Ag
15.11 Shire Plc
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Non-Alcoholic Steatohepatitis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
8.2 Online Provider
8.3 Retail Pharmacy
9. Non-Alcoholic Steatohepatitis Market - By Drug Type (Market Size -$Million / $Billion)
9.1 Vitamin E Pioglitazone
9.2 Obeticholic Acid
9.3 Elafibranor
9.4 Selonsertib Cenicriviroc
10. Non-Alcoholic Steatohepatitis - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Non-Alcoholic Steatohepatitis- By Geography (Market Size -$Million / $Billion)
11.1 Non-Alcoholic Steatohepatitis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Non-Alcoholic Steatohepatitis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Non-Alcoholic Steatohepatitis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Non-Alcoholic Steatohepatitis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Non-Alcoholic Steatohepatitis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Non-Alcoholic Steatohepatitis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Non-Alcoholic Steatohepatitis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Non-Alcoholic Steatohepatitis Market - Key Company List by Country Premium
15. Non-Alcoholic Steatohepatitis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Allergan Plc
15.3 Cadila Healthcare Ltd
15.4 Conatus Pharmaceuticals, Inc
15.5 Galmed Pharmaceutical Ltd
15.6 Gemphire Therapeutic Inc
15.7 Genfit Sa
15.8 Gilead Sciences, Inc
15.9 Intercept Pharmaceuticals, Inc
15.10 Novartis International Ag
15.11 Shire Plc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Non-Alcoholic Steatohepatitis Market - Appendix16.1 Abbreviations
16.2 Sources
17. Non-Alcoholic Steatohepatitis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)1.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Global Industry Research
1.2 Obeticholic Acid Market 2023-2030 ($M) - Global Industry Research
1.3 Elafibranor Market 2023-2030 ($M) - Global Industry Research
1.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Global Industry Research
2.Global Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
2.1 Hospital Pharmacy Market 2023-2030 ($M) - Global Industry Research
2.2 Online Provider Market 2023-2030 ($M) - Global Industry Research
2.3 Retail Pharmacy Market 2023-2030 ($M) - Global Industry Research
3.Global Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 (Volume/Units)
3.1 Vitamin E Pioglitazone Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Obeticholic Acid Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Elafibranor Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Selonsertib Cenicriviroc Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 (Volume/Units)
4.1 Hospital Pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Online Provider Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Retail Pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)
5.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Regional Industry Research
5.2 Obeticholic Acid Market 2023-2030 ($M) - Regional Industry Research
5.3 Elafibranor Market 2023-2030 ($M) - Regional Industry Research
5.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Regional Industry Research
6.North America Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
6.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
6.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
6.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
7.South America Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)
7.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Regional Industry Research
7.2 Obeticholic Acid Market 2023-2030 ($M) - Regional Industry Research
7.3 Elafibranor Market 2023-2030 ($M) - Regional Industry Research
7.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Regional Industry Research
8.South America Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
8.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
8.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
8.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
9.Europe Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)
9.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Regional Industry Research
9.2 Obeticholic Acid Market 2023-2030 ($M) - Regional Industry Research
9.3 Elafibranor Market 2023-2030 ($M) - Regional Industry Research
9.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Regional Industry Research
10.Europe Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
10.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
10.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
10.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
11.APAC Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)
11.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Regional Industry Research
11.2 Obeticholic Acid Market 2023-2030 ($M) - Regional Industry Research
11.3 Elafibranor Market 2023-2030 ($M) - Regional Industry Research
11.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Regional Industry Research
12.APAC Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
12.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
12.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
12.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
13.MENA Nonalcoholic Steatohepatitis Market, By Drug Type Market 2023-2030 ($M)
13.1 Vitamin E Pioglitazone Market 2023-2030 ($M) - Regional Industry Research
13.2 Obeticholic Acid Market 2023-2030 ($M) - Regional Industry Research
13.3 Elafibranor Market 2023-2030 ($M) - Regional Industry Research
13.4 Selonsertib Cenicriviroc Market 2023-2030 ($M) - Regional Industry Research
14.MENA Nonalcoholic Steatohepatitis Market, By Sale Channel Market 2023-2030 ($M)
14.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
14.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
14.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)2.Canada Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
3.Mexico Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
4.Brazil Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
5.Argentina Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
6.Peru Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
7.Colombia Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
8.Chile Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
9.Rest of South America Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
10.UK Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
11.Germany Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
12.France Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
13.Italy Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
14.Spain Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
16.China Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
17.India Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
18.Japan Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
19.South Korea Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
20.South Africa Non-Alcoholic Steatohepatitis Market Revenue, 2023-2030 ($M)
21.North America Non-Alcoholic Steatohepatitis By Application
22.South America Non-Alcoholic Steatohepatitis By Application
23.Europe Non-Alcoholic Steatohepatitis By Application
24.APAC Non-Alcoholic Steatohepatitis By Application
25.MENA Non-Alcoholic Steatohepatitis By Application
26.Allergan Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Cadila Healthcare Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Conatus Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Galmed Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Gemphire Therapeutic Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Genfit Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Gilead Sciences, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Intercept Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Novartis International Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Shire Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)